Clinical Remission in Severe T2 high Asthma : A real-word analysis with Omalizumab, Mepolizumab and Benralizumab.
Year: 2024
Type: conference-abstract
Institution: Centre Hospitalier Universitaire de Liège
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4404101488
